Economic benefits of safety-engineered sharp devices in Belgium - a budget impact model

被引:0
|
作者
Emma Hanmore
Grant Maclaine
Fiona Garin
Alexander Alonso
Nicolas Leroy
Lewis Ruff
机构
[1] Medaxial Ltd.,Becton
[2] Dickinson UK Ltd.,Becton
[3] Dickinson SA,Becton
[4] Dickinson Benelux NV,undefined
关键词
Budget; Model; Economic; Needlestick; Safety-engineered; Device;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] The economic benefits of increased sugar-free chewing gum in China: a budget impact analysis
    Du, Shuo
    Zhang, Chunzi
    Wang, Wenhui
    Liu, Jian
    Yuan, Chao
    Yu, Yizhen
    Chang, Qing
    Zhang, Shanshan
    Si, Yan
    BMC ORAL HEALTH, 2021, 21 (01)
  • [32] Budget impact analysis of Mimpara among dialysis patients in Belgium using a Markov simulation model
    Roze, S
    Palmer, AJ
    Standaert, B
    Van Kriekinge, G
    VALUE IN HEALTH, 2005, 8 (06) : A78 - A78
  • [33] A partial budget model to estimate economic benefits of lactational treatment of subclinical Staphylococcus aureus mastitis
    Swinkels, JM
    Hogeveen, H
    Zadoks, RN
    JOURNAL OF DAIRY SCIENCE, 2005, 88 (12) : 4273 - 4287
  • [34] BENEFITS OF A POLYMER TIP IN TORSIONAL PHACOEMULSIFICATION: A TARGETED LITERATURE SEARCH AND BUDGET IMPACT MODEL
    Hsiao, C. W.
    Wright, G.
    Son, D.
    Pan, L. C.
    VALUE IN HEALTH, 2024, 27 (06) : S136 - S137
  • [35] ECONOMIC BENEFITS OF SFLT-1/PLGF TESTING FOR PREECLAMPSIA IN COLOMBIA: A FIVER YEAR BUDGET IMPACT ANALYSIS
    Duva, A. S.
    Rosim, R. P.
    Ballalai Ferraz, A. F.
    Cachoeira, C.
    Mojica, I. L.
    VALUE IN HEALTH, 2017, 20 (09) : A864 - A864
  • [36] A BUDGET IMPACT MODEL TO EVALUATE THE ECONOMIC IMPACT OF TREATING WALKING IMPAIRMENT IN CHRONIC STROKE, A US PERSPECTIVE
    Kane, S.
    Jayawardena, N.
    Bourque, M.
    Lavanture, J.
    Roberts, H.
    VALUE IN HEALTH, 2023, 26 (06) : S143 - S143
  • [37] Economic and budget impact model of maintenance treatment of CIDP with IgPro20 in the US
    Mallick, Rajiv
    Carlton, Rashad
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 342 - 343
  • [38] A BUDGET IMPACT MODEL FOR THE ECONOMIC ASSESSMENT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS IN ITALY
    Iannazzo, S.
    Zaniolo, O.
    Giuliani, G.
    VALUE IN HEALTH, 2010, 13 (07) : A305 - A305
  • [39] Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model
    Patterson, Brandon J.
    Herring, William L.
    Van Oorschot, Desiree
    Curran, Desmond
    Carrico, Justin
    Zhang, Yuanhui
    Ackerson, Bradley K.
    Bruxvoort, Katia
    Sy, Lina S.
    Tseng, Hung-Fu
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (12): : 1567 - 1575
  • [40] A BUDGET IMPACT MODEL TO ESTIMATE THE ECONOMIC IMPACT OF ITRACONAZOLE IN PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH NEUTROPENIA IN SPAIN
    Darba, J.
    Restovic, G.
    VALUE IN HEALTH, 2009, 12 (07) : A419 - A419